These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 18298597)

  • 21. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
    Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
    Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
    Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants.
    De Boer F; Dräger AM; Van der Wall E; Pinedo HM; Schuurhuis GJ
    Bone Marrow Transplant; 1998 Dec; 22(11):1103-10. PubMed ID: 9877274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
    Rodríguez L; Velasco B; García J; Martín-Henao GA
    Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for Cryobiology and Biology of Bone Marrow Transplantation (CBTMO), Spain.
    Perez-Oteyza J; Bornstein R; Corral M; Hermosa V; Alegre A; Torrabadella M; Ramos P; Garcia J; Odriozola J; Navarro JL
    Haematologica; 1998 Nov; 83(11):1001-5. PubMed ID: 9864921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide.
    Motta JP; Gomes BE; Bouzas LF; Paraguassú-Braga FH; Porto LC
    Cryobiology; 2010 Jun; 60(3):301-7. PubMed ID: 20152822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.
    Kurtz J; Seetharaman S; Greco N; Moroff G
    Transfusion; 2007 Sep; 47(9):1578-87. PubMed ID: 17725720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
    Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
    Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term cryopreservation of peripheral blood stem cells in patients with advanced germ cell tumors using the dump-freezing method at -80 degrees C.
    Muramaki M; Hara I; Miyake H; Yamada Y; Okada H; Kamidono S
    Oncol Rep; 2003; 10(6):1993-8. PubMed ID: 14534732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.
    Dijkstra-Tiekstra MJ; Setroikromo AC; Kraan M; Gkoumassi E; de Wildt-Eggen J
    Transfusion; 2014 Dec; 54(12):3155-63. PubMed ID: 25109216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cord blood thawing methods on cell recovery, potency, and infusion.
    Regan DM; Wofford JD; Wall DA
    Transfusion; 2010 Dec; 50(12):2670-5. PubMed ID: 21126251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells.
    Yang H; Pidgorna A; Loutfy MR; Shuen P
    Transfusion; 2015 Jan; 55(1):70-8. PubMed ID: 25039650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells.
    Campos L; Roubi N; Guyotat D
    Cryobiology; 1995 Dec; 32(6):511-5. PubMed ID: 8556857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryopreservation.
    Balint B; Vucetić D; Trajković-Lakić Z; Petakov M; Bugarski D; Brajusković G; Taseski J
    Haematologia (Budap); 2002; 32(4):363-75. PubMed ID: 12803111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cryobiological responses in TF-1 cells using interrupted freezing procedures.
    Ross-Rodriguez LU; Elliott JA; McGann LE
    Cryobiology; 2010 Apr; 60(2):106-16. PubMed ID: 19766619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a cryopreservation protocol for type A spermatogonia.
    Izadyar F; Matthijs-Rijsenbilt JJ; den Ouden K; Creemers LB; Woelders H; de Rooij DG
    J Androl; 2002; 23(4):537-45. PubMed ID: 12065461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution.
    Clarke DM; Yadock DJ; Nicoud IB; Mathew AJ; Heimfeld S
    Cytotherapy; 2009; 11(4):472-9. PubMed ID: 19499402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.
    Stylianou J; Vowels M; Hadfield K
    Cytotherapy; 2006; 8(1):57-61. PubMed ID: 16627345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.